... signaling via CD20CommentaryB cells as a therapeutic target in autoimmune diseaseJörg J Goronzy and Cornelia M WeyandDepartments of Medicine and Immunology, Mayo Clinic, Rochester, MN, USACorresponding ... diseases. Preliminary clinical studies suggest therapeutic benefits in patients with classicautoantibody-mediated syndromes, such as autoimmune cytopenias. Treatment responses in rheumatoid arthritis ... still has anaccepted role in thrombotic thrombocytopenic purpuraand cryoglobulinemia; however, in other chronic inflamma-tory diseases, plasmapheresis has had disappointingresults. After 1980,...